GUTS
Price
$1.29
Change
-$0.09 (-6.52%)
Updated
Oct 27, 04:59 PM (EDT)
Capitalization
182.43M
22 days until earnings call
Intraday Buy/Sell Signals
MNKD
Price
$5.42
Change
+$0.11 (+2.07%)
Updated
Oct 27 closing price
Capitalization
1.63B
14 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

GUTS vs MNKD

Header iconGUTS vs MNKD Comparison
Open Charts GUTS vs MNKDBanner chart's image
Fractyl Health
Price$1.29
Change-$0.09 (-6.52%)
Volume$17.89K
Capitalization182.43M
MannKind
Price$5.42
Change+$0.11 (+2.07%)
Volume$2.69M
Capitalization1.63B
GUTS vs MNKD Comparison Chart in %
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GUTS vs. MNKD commentary
Oct 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GUTS is a Hold and MNKD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 28, 2025
Stock price -- (GUTS: $1.30 vs. MNKD: $5.42)
Brand notoriety: GUTS and MNKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GUTS: 42% vs. MNKD: 53%
Market capitalization -- GUTS: $182.43M vs. MNKD: $1.63B
GUTS [@Biotechnology] is valued at $182.43M. MNKD’s [@Biotechnology] market capitalization is $1.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GUTS’s FA Score shows that 0 FA rating(s) are green whileMNKD’s FA Score has 0 green FA rating(s).

  • GUTS’s FA Score: 0 green, 5 red.
  • MNKD’s FA Score: 0 green, 5 red.
According to our system of comparison, MNKD is a better buy in the long-term than GUTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GUTS’s TA Score shows that 6 TA indicator(s) are bullish while MNKD’s TA Score has 4 bullish TA indicator(s).

  • GUTS’s TA Score: 6 bullish, 4 bearish.
  • MNKD’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, both GUTS and MNKD are a good buy in the short-term.

Price Growth

GUTS (@Biotechnology) experienced а -6.47% price change this week, while MNKD (@Biotechnology) price change was -1.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.69%. For the same industry, the average monthly price growth was +11.04%, and the average quarterly price growth was +64.46%.

Reported Earning Dates

GUTS is expected to report earnings on Nov 18, 2025.

MNKD is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (-0.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNKD($1.63B) has a higher market cap than GUTS($182M). MNKD YTD gains are higher at: -15.708 vs. GUTS (-33.010). MNKD has higher annual earnings (EBITDA): 79.1M vs. GUTS (-98.85M). MNKD has more cash in the bank: 179M vs. GUTS (22.3M). MNKD has less debt than GUTS: MNKD (46.8M) vs GUTS (61.7M). MNKD has higher revenues than GUTS: MNKD (302M) vs GUTS (17K).
GUTSMNKDGUTS / MNKD
Capitalization182M1.63B11%
EBITDA-98.85M79.1M-125%
Gain YTD-33.010-15.708210%
P/E RatioN/A49.27-
Revenue17K302M0%
Total Cash22.3M179M12%
Total Debt61.7M46.8M132%
FUNDAMENTALS RATINGS
MNKD: Fundamental Ratings
MNKD
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
49
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GUTSMNKD
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
Momentum
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
75%
MACD
ODDS (%)
Bearish Trend 4 days ago
87%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
76%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 4 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
88%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACGP37.050.48
+1.31%
Associated Capital Group, Inc.
CUYTY9.35N/A
N/A
COLRUYT GROUP N.V.
XTMIF0.02N/A
N/A
XTM Inc.
ARLUF40.01N/A
N/A
Aristocrat Leisure Ltd.
LOMLF0.19N/A
-0.63%
Lion One Metals Ltd.

GUTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GUTS has been loosely correlated with RCKT. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if GUTS jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GUTS
1D Price
Change %
GUTS100%
N/A
RCKT - GUTS
33%
Loosely correlated
+2.94%
NEVPF - GUTS
31%
Poorly correlated
N/A
UNCY - GUTS
31%
Poorly correlated
+5.56%
MNKD - GUTS
30%
Poorly correlated
-3.28%
SPRB - GUTS
29%
Poorly correlated
+2.56%
More